Researchers testing CAR T-Cell therapy to treat multiple sclerosis
UC expert featured in Precision Medicine Online article
The University of Cincinnati's Aram Zabeti was featured in a Precision Medicine Online article discussing a new trial testing CAR T-cell therapy to treat multiple sclerosis.
UC is a trial site for the Phase 1 Breakfree-2 trial, sponsored by Bristol Myers Squibb. MS occurs when the immune system mistakenly attacks the myelin that protects and covers nerve fibers, disrupting the communication between the brain and the rest of the body and leading to a wide range of symptoms.
In CAR T-cell therapy, patient's immune cells are collected and genetically modified to recognize and eliminate the malfunctioning immune cells that drive MS. Once modified, they are infused back into the patient.
"We want to make sure they're safe," and that the new cells do not cause additional harm or damage, said Zabeti, associate professor of neurology at UC’s College of Medicine and director of the Waddell Center for MS. "We're hoping [patients] might not need any re-treatment," he added, but that's an area in need of further study.
Read the Precision Medicine Online article.
Read more about the trial at UC.
For more information on trial eligibility and enrollment for this and other MS trials open at UC, please contact trial coordinator Sara Esmaeli at esmaeisr@ucmail.uc.edu.
Featured photo at top illustrating CAR-T cells attacking a malfunctioning immune cell. Photo/selvanegra/iStock Photo.
Related Stories
From the pitch to personal impact
May 11, 2026
Hoxworth Blood Center, University of Cincinnati, is uniting blood donors around one shared mission — saving lives close to home — through two unique blood drives this May. From the FC Cincinnati Blood Drive at TQL Stadium to an event honoring local blood recipient and cancer survivor John Mattingly, these blood drives offer meaningful ways to give back. Whether inspired by hometown pride or a powerful personal story, blood donors are encouraged to roll up their sleeves and help ensure life-saving blood is available for patients across the Tristate. Patients at local hospitals depend on blood donations every day, and community support is critical to maintaining a strong supply.
GE Aerospace workforce training focuses on Dayton workers
May 11, 2026
GE Aerospace is launching more employee training at its Beavercreek Plant. The Dayton Daily News talks to the company's site leader, a University of Cincinnati graduate who got his start at GE Aerospace through UC's co-op program.
UC Blue Ash announces 2026 outstanding alumni award winner
May 11, 2026
Mark Brueggeman has enjoyed a long and successful business career that includes launching his own petrochemical distribution company that has clients around the world and grosses more than $150 million per year.